Using ERG protocols similar to those validated in rodent studies, we have demonstrated improvements in RGC function in humans, as early as 3-months following IOP-lowering in glaucoma. Recent work has significantly improved repeatability of the PhNR measurement, enabling detection of subtle changes in inner retinal function.